Regulation of Thrombin-Induced Lung Endothelial Cell Barrier Disruption by Protein Kinase C Delta

Lishi Xie1,2, Eddie T Chiang3, Xiaomin Wu3

  • 1Institute for Personalized Respiratory Medicine, University of Illinois at Chicago, Chicago, Illinois, United States of America.

Plos One
|July 22, 2016
PubMed

Insights

Protein Kinase C delta (PKCδ) worsens endothelial cell barrier dysfunction during thrombin exposure. This isoform regulates cytoskeleton dynamics, offering a potential therapeutic target for lung injury and sepsis.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Physiology

Background:

  • Protein Kinase C (PKC) isozymes regulate endothelial cell (EC) barrier function.
  • Understanding specific PKC isoform roles in vascular homeostasis is crucial.

Purpose of the Study:

  • To elucidate the role of the PKCδ isoform in thrombin-induced loss of human pulmonary artery EC barrier integrity.
  • To identify downstream signaling pathways regulated by PKCδ in ECs.

Main Methods:

  • Inhibitory studies using rottlerin.
  • Expression of dominant-negative PKCδ construct.
  • PKCδ silencing via siRNA.
  • Assessment of MLC phosphorylation and Rho GTPase activation.
  • Analysis of cytoskeleton rearrangement and EC barrier function.

Main Results:

  • PKCδ isoform was identified as a key mediator promoting thrombin-induced EC barrier loss.
  • PKCδ activation positively feedbacks on Rho GTPase and inhibits Rac1 GTPase.
  • PKCδ targets, PKD (PKCμ) and CPI-17, were activated and modulated EC cytoskeleton.

Conclusions:

  • PKCδ plays a critical role in regulating EC cytoskeleton and barrier integrity.
  • PKCδ is a potential therapeutic target for inflammatory lung disorders like acute lung injury and sepsis.

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.7K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.9K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.0K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
9.1K